Ian McFadden

5PUBLICATIONS
22CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 01, 2026
Real-World Utilization and Initial Experience with Aflibercept-ayyh (PAVBLU<sup>®</sup>) for Retinal Disorders in United States Retina Practices: A Descriptive Retrospective Analysis.

|Mar 31, 2025
Correction to: Evolution of frontline treatment for multiple myeloma: clinical investigation of quadruplets containing carflzomib and antiCD38 monoclonal antibodies.

Luciano J Costa, Francesca Gay, Ola Landgren

|Jan 08, 2025
Evolution of frontline treatment for multiple myeloma: clinical investigation of quadruplets containing carfilzomib and anti-CD38 monoclonal antibodies.

Luciano J Costa, Francesca Gay, Ola Landgren

|May 20, 2024
EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma.

Ola Landgren, Thomas J Prior, Tara Masterson

|Mar 18, 2024
An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd): SELECT study.

Aurore Perrot, Sosana Delimpasi, Emmanouil Spanoudakis

Pageof 1

Frequent Collaborators

3 joint publications

Philippe Moreau

3 joint publications

Ola Landgren

2 joint publications

Cyrille Touzeau

2 joint publications

María-Victoria Mateos